tiprankstipranks
Advertisement
Advertisement
Caris Life Sciences price target lowered to $30 from $31 at TD Cowen
PremiumThe FlyCaris Life Sciences price target lowered to $30 from $31 at TD Cowen
1M ago
Caris Life Sciences expands prostate cancer offering with PTEN IHC testing
Premium
The Fly
Caris Life Sciences expands prostate cancer offering with PTEN IHC testing
1M ago
Caris Life Sciences price target lowered to $23 from $28 at BofA
Premium
The Fly
Caris Life Sciences price target lowered to $23 from $28 at BofA
1M ago
Caris Life Sciences announces dual listing on NYSE Texas
PremiumThe FlyCaris Life Sciences announces dual listing on NYSE Texas
2M ago
Caris Life Sciences announces $100M share repurchase program
Premium
The Fly
Caris Life Sciences announces $100M share repurchase program
2M ago
Caris Life Sciences assumed with a Peer Perform at Wolfe Research
Premium
The Fly
Caris Life Sciences assumed with a Peer Perform at Wolfe Research
3M ago
Caris Life Sciences price target lowered to $32 from $38 at BTIG
PremiumThe FlyCaris Life Sciences price target lowered to $32 from $38 at BTIG
3M ago
Caris Life Sciences price target lowered to $30 from $35 at JPMorgan
Premium
The Fly
Caris Life Sciences price target lowered to $30 from $35 at JPMorgan
3M ago
Caris Life Sciences price target lowered to $28 from $35 at Citi
Premium
The Fly
Caris Life Sciences price target lowered to $28 from $35 at Citi
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100